182
Views
20
CrossRef citations to date
0
Altmetric
Migraine

Sumatriptan (50 mg tablets vs. 25 mg suppositories) in the acute treatment of menstrually related migraine and oral contraceptive-induced menstrual migraine: a pilot study

, , , , , , , & show all
Pages 773-779 | Received 30 Dec 2009, Accepted 15 Apr 2010, Published online: 08 Jun 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Lara Tiranini, Laura Cucinella, Silvia Martella, David Bosoni, Ellis Martini & Rossella E. Nappi. (2023) Is now the time to reconsider risks, benefits, and limitations of estrogen preparations as a treatment for menstrually related migraine?. Expert Review of Neurotherapeutics 23:4, pages 377-388.
Read now
Claire E. J. Ceriani & Stephen D. Silberstein. (2023) Current and emerging pharmacotherapy for menstrual migraine: a narrative review. Expert Opinion on Pharmacotherapy 24:5, pages 617-627.
Read now
G. Allais, Giulia Chiarle, Silvia Sinigaglia & Chiara Benedetto. (2018) Menstrual migraine: a review of current and developing pharmacotherapies for women. Expert Opinion on Pharmacotherapy 19:2, pages 123-136.
Read now
Stephen Silberstein & Sumit Patel. (2014) Menstrual migraine: an updated review on hormonal causes, prophylaxis and treatment. Expert Opinion on Pharmacotherapy 15:14, pages 2063-2070.
Read now
Luana Lionetto, Andrea Negro, Barbara Casolla, Maurizio Simmaco & Paolo Martelletti. (2012) Sumatriptan succinate: pharmacokinetics of different formulations in clinical practice. Expert Opinion on Pharmacotherapy 13:16, pages 2369-2380.
Read now
Gennaro Bussone, Gianni Allais, Ilaria Castagnoli Gabellari & Chiara Benedetto. (2011) Almotriptan for menstrually related migraine. Expert Opinion on Pharmacotherapy 12:12, pages 1933-1943.
Read now

Articles from other publishers (14)

Iris E Verhagen, Hermes AJ Spaink, Britt WH van der Arend, Daphne S van Casteren, Antoinette MaassenVanDenBrink & Gisela M Terwindt. (2022) Validation of diagnostic ICHD-3 criteria for menstrual migraine. Cephalalgia 42:11-12, pages 1184-1193.
Crossref
Hannah J. Roeder & Enrique C. Leira. (2021) Effects of the Menstrual Cycle on Neurological Disorders. Current Neurology and Neuroscience Reports 21:7.
Crossref
Raffaele Ornello, Eleonora De Matteis, Chiara Di Felice, Valeria Caponnetto, Francesca Pistoia & Simona Sacco. (2021) Acute and Preventive Management of Migraine during Menstruation and Menopause. Journal of Clinical Medicine 10:11, pages 2263.
Crossref
Peer Tfelt-Hansen, Janus Kaufmann Lindqvist & Thien Phu Do. (2018) Evaluating the reporting of adverse events in controlled clinical trials conducted in 2010–2015 on migraine drug treatments. Cephalalgia 38:12, pages 1885-1895.
Crossref
Kasra Maasumi, Stewart J. Tepper & Jennifer S. Kriegler. (2017) Menstrual Migraine and Treatment Options: Review. Headache: The Journal of Head and Face Pain 57:2, pages 194-208.
Crossref
Hida del C. Nierenburg, Jessica Ailani, Michele Malloy, Sara Siavoshi, Nancy N. Hu & Nadia Yusuf. (2015) Systematic Review of Preventive and Acute Treatment of Menstrual Migraine. Headache: The Journal of Head and Face Pain 55:8, pages 1052-1071.
Crossref
Yong Hu, Xiaofei Guan, Lin Fan & Lingjing Jin. (2013) Triptans in prevention of menstrual migraine: a systematic review with meta-analysis. The Journal of Headache and Pain 14:1.
Crossref
G. Allais, V. Tullo, S. Omboni, D. Pezzola, D. Zava, C. Benedetto & G. Bussone. (2013) Frovatriptan vs. other triptans for the acute treatment of oral contraceptive-induced menstrual migraine: pooled analysis of three double-blind, randomized, crossover, multicenter studies. Neurological Sciences 34:S1, pages 83-86.
Crossref
Gianni Allais & Chiara Benedetto. (2012) A review of the use of frovatriptan in the treatment of menstrually related migraine. Therapeutic Advances in Neurological Disorders 6:2, pages 55-67.
Crossref
Gianni Allais, Ilaria Castagnoli Gabellari, Ornella Mana & Chiara Benedetto. (2012) Treatment Strategies for Menstrually Related Migraine. Women's Health 8:5, pages 529-541.
Crossref
Marco Bartolini, Maria Adelaide Giamberardino, Carlo Lisotto, Paolo Martelletti, Davide Moscato, Biagio Panascia, Lidia Savi, Luigi Alberto Pini, Grazia Sances, Patrizia Santoro, Giorgio Zanchin, Stefano Omboni, Michel D. Ferrari, Brigida Fierro & Filippo Brighina. (2012) Frovatriptan versus almotriptan for acute treatment of menstrual migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study. The Journal of Headache and Pain 13:5, pages 401-406.
Crossref
Lidia Savi, Stefano Omboni, Carlo Lisotto, Giorgio Zanchin, Michel D. Ferrari, Dario Zava & Lorenzo Pinessi. (2011) Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study versus rizatriptan. The Journal of Headache and Pain 12:6, pages 609-615.
Crossref
Gianni Allais, Vincenzo Tullo, Chiara Benedetto, Dario Zava, Stefano Omboni & Gennaro Bussone. (2011) Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, multicenter, Italian, comparative study versus zolmitriptan. Neurological Sciences 32:S1, pages 99-104.
Crossref
E. Anne MacGregor. (2011) Progress in the Pharmacotherapy of Menstrual Migraine. Clinical Medicine Insights: Therapeutics 3, pages CMT.S6170.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.